ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,252Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 807

$605K Total Retail Price of All Prescriptions

Rank: 65 out of 807

541 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,296 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 523 497 1 1
AMLODIPINE BESYLATE 384 367 2 5
LEVOTHYROXINE SODIUM 372 347 3 3
OMEPRAZOLE 350 292 4 4
LISINOPRIL 310 290 5 2
ATENOLOL 297 283 6 7
POTASSIUM CHLORIDE 278 260 7 18
FUROSEMIDE 254 241 8 6
HYDROCHLOROTHIAZIDE 219 210 9 9
LOSARTAN POTASSIUM 212 197 10 14
ATORVASTATIN CALCIUM 208 195 11 11
WARFARIN SODIUM 201 191 12 10
ALENDRONATE SODIUM 189 176 13 20
HYDROCODONE-ACETAMINOPHEN 180 146 S3 14 15
METOPROLOL SUCCINATE 178 166 15 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 172 161 16 28
TRAZODONE HCL 138 116 17 25
LOSARTAN-HYDROCHLOROTHIAZIDE 136 134 18 55
GABAPENTIN 131 104 19 16
METOPROLOL TARTRATE 130 130 20 8
ZOLPIDEM TARTRATE 123 98 21 23
CITALOPRAM HBR 118 101 22 17
CRESTOR 99 81 23 32
ALLOPURINOL 95 95 24 26
METFORMIN HCL 95 74 24 12
GLIMEPIRIDE 93 72 26 51
DONEPEZIL HCL 92 92 27 31
NAMENDA 84 84 28 54
PREDNISONE 81 80 29 24
PANTOPRAZOLE SODIUM 76 70 30 44
FENOFIBRATE 71 68 31 69
JANUVIA 71 61 31 79
AMLODIPINE BESYLATE-BENAZEPRIL 69 69 33 117
ADVAIR DISKUS 66 63 34 33
NEXIUM 66 66 34 68
RANITIDINE HCL 63 49 36 34
TAMSULOSIN HCL 63 58 36 27
TRAMADOL HCL 61 61 38 19
HYDRALAZINE HCL 60 60 39 62
PRAVASTATIN SODIUM 60 43 39 21
PROPRANOLOL HCL 60 60 39 101
CALCITRIOL 57 53 42 142
TRIAMTERENE-HCTZ 55 51 43 29
MELOXICAM 52 36 44 105
AZITHROMYCIN 51 46 45 57
DIGOXIN 50 50 46 41
OXYCODONE-ACETAMINOPHEN 50 23 S2 46 56
FLUTICASONE PROPIONATE 50 42 46 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.